Precision Neuroscience

company

About

Precision Neuroscience is a neural platform that engages in brain-computer interface technology.

Details

Last Funding Type
Series Unknown
Last Funding Money Raised
$34.30M
Industries
Medical,Medical Device,Neuroscience,Product Research
Founded date
May 1, 2021
Number Of Employee
11 - 50
Operating Status
Active
Legal Name
Precision Neuroscience Corporation

Precision Neuroscience is a neural platform for next-generation brain-computer interface technology. The company's goal is to provide breakthrough treatments for the one billion patients worldwide suffering from neurological illnesses. Its brain–computer interface is designed to be minimally invasive, safely removable, and capable of processing large amounts of data.

The company was founded in 2021 and is based in New York.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$46.30M
Precision Neuroscience has raised a total of $46.30M in funding over 2 rounds. Their latest funding was raised on Dec 19, 2022 from a Series Unknown round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Dec 19, 2022 Series Unknown $34.30M Detail
May 25, 2021 Series A $12M 2 B Capital Group
Steadview Capital
Detail

Investors

Number of Lead Investors
Number of Investors
2
2
Precision Neuroscience is funded by 2 investors. B Capital Group and Steadview Capital are the most recent investors.
Investor Name Lead Investor Funding Round
B Capital Group Yes Series A
Steadview Capital Yes Series A

Employee Profiles

Number of Employee Profiles
4
Precision Neuroscience has 4 current employee profiles, including Executive Demetrios Papageorgiou
Executive
Executive
Executive